December 12, 2025

Ozempic Semaglutide Therapy Launches in India for Type 2 Diabetes

Novo Nordisk has introduced Ozempic, a weekly semaglutide injection for adults with type 2 diabetes, now available in India at affordable prices. It offers better blood sugar control, weight management, and heart-kidney protection.

December 12, 2025

Indian Firms Back ESG Rules but Struggle with High Costs, Lack Sector-Specific Reporting: Study

A joint study by Kerala University and Indian Institute of Forest Management shows Indian companies support ESG integration under BRSR but face big challenges like costly investments and poor sector guidelines. Banks lead compliance, manufacturers lead green actions, while services face the most trouble.

December 12, 2025

NLC India Limited Regularises 397 IndcoServe Workers, Boosting Employee Welfare

NLC India Limited has regularised 397 long-serving IndcoServe society workers. Union Minister G. Kishan Reddy said this shows progress built on respect and inclusion. The company plans more support with health and skill programmes.

December 12, 2025

Novo Nordisk launches Ozempic injection for Type 2 diabetes in India at Rs 2,200/week

Novo Nordisk launched Ozempic, a popular type 2 diabetes injection with weight loss benefits, in India. Available as a weekly injection, prices start at Rs 2,200 per dose. The company aims to offer affordable and innovative treatment to diabetes patients nationwide.

December 12, 2025

ATO's $500,000 Outsourcing Cut Target Criticized as 'Woefully Inadequate'

The Australian Taxation Office aims to cut outsourcing by just $500,000 this year. Critics call this tiny reduction disappointing amid government calls to bring more work in-house and reduce contractor use.